Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi's sarcoma: an AIDS Malignancy Consortium Study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples